» Articles » PMID: 39433445

Comparative Effectiveness of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Vs Open Radical Cystectomy for Bladder Cancer

Overview
Journal BJU Int
Specialty Urology
Date 2024 Oct 21
PMID 39433445
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess the comparative effectiveness of robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) vs open radical cystectomy (ORC) for bladder cancer (BC).

Patients And Methods: We conducted a real-life monocentric study including all consecutive patients who underwent RARC with ICUD or ORC for BC at our institution from 2014 to 2023. Uni- and multivariable logistic and Cox regression analyses were used to compare perioperative, oncological and stricture outcomes between both groups by calculating odds (ORs) and hazard (HRs) ratios with their corresponding 95% confidence intervals (CIs), respectively.

Results: Overall, 316 patients underwent either RARC with ICUD (n = 228 [72.2%]) or ORC (n = 88 [27.8%]). The perioperative benefits of RARC vs ORC included decreased risks of major blood loss (OR 0.10, 95% CI 0.04-0.23; P < 0.001), perioperative transfusion (OR 0.30, 95% CI 0.16-0.57; P < 0.001), 90-day major complications (OR 0.56, 95% CI 0.29-0.99; P = 0.04), and prolonged initial length of hospital stay (OR 0.20, 95% CI 0.09-0.35; P < 0.001), as well as more days alive and out of the hospital within 90 days of surgery (OR 2.56, 95% CI 1.46-4.6; P < 0.01). In addition, the use of RARC vs ORC was associated with a higher lymph node (LN) count (OR 3.35, 95% CI 1.83-6.30; P < 0.001), while there was no significant difference in recurrence-free (HR 0.72, 95% CI 0.49-1.07; P = 0.1), cancer-specific (HR 0.69, 95% CI 0.43-1.10; P = 0.1), overall (HR 0.76, 95% CI 0.47-1.20; P = 0.3) and uretero-ileal stricture-free (HR 1.18, 95% CI 0.62-2.25; P = 0.6) survival between both groups after a median (interquartile range) follow-up of 42.3 (16.4-73.8) months.

Conclusion: Our real-world study supports the effectiveness of RARC with ICUD vs ORC for BC. We generally observed better perioperative outcomes, as well as similar oncological-except for higher LN count-and uretero-ileal stricture outcomes after RARC with ICUD vs ORC.

References
1.
Yuh B, Wilson T, Bochner B, Chan K, Palou J, Stenzl A . Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Eur Urol. 2015; 67(3):402-22. DOI: 10.1016/j.eururo.2014.12.008. View

2.
Parekh D, Messer J, FitzGerald J, Ercole B, Svatek R . Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy. J Urol. 2012; 189(2):474-9. DOI: 10.1016/j.juro.2012.09.077. View

3.
Fu S, Shi H, Fan Z, Li J, Luan T, Dong H . Robot-assisted radical cystectomy with intracorporeal urinary diversion: an updated systematic review and meta-analysis of its differential effect on effectiveness and safety. Int J Surg. 2024; 110(4):2366-2380. PMC: 11020008. DOI: 10.1097/JS9.0000000000001065. View

4.
Witjes J, Bruins H, Carrion A, Cathomas R, Comperat E, Efstathiou J . European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol. 2023; 85(1):17-31. DOI: 10.1016/j.eururo.2023.08.016. View

5.
Bochner B, Dalbagni G, Sjoberg D, Silberstein J, Paz G, Donat S . Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2014; 67(6):1042-1050. PMC: 4424172. DOI: 10.1016/j.eururo.2014.11.043. View